Fresenius Kabi Austria company information, Employees & Contact Information

Fresenius Kabi Announces 13 New Inductees Into the National Blood Donation Hall of Fame Business Wire

Fresenius Kabi Receives Two Major Awards for Supply and Service Excellence from Vizient® Yahoo Finance

Blood Products Administration Set Recall from Fresenius Kabi fda.gov

CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code for Conexxence® and Bomyntra® (denosumab-bnht) Yahoo Finance

Update on Alert: Infusion Pump Software Issue from Fresenius Kabi USA fda.gov

FDA Grants Interchangeable Designation to Fresenius Kabi’s biosimilar Otulfi® (ustekinumab-aauz) Business Wire

Fresenius Kabi Receives 2025 Premier Supplier Legacy Award Yahoo Finance

Fresenius Kabi and AABB Announce 20th Anniversary of Blood Collectors Week, September 7–14, 2025, Honoring Lifesaving Blood Collection Professionals Business Wire

Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016 Yahoo Finance

Fresenius Kabi Introduces Epinephrine Injection, USP, in 30 mg per 30 mL Multi-Dose Vials Business Wire

Fresenius Kabi Canada launches Iodixanol Injection 270 & 320 - the first and only generic to Visipaque® in Canada Yahoo Finance

Fresenius Expands Biosimilars Portfolio With The Launch of Denosumab Biosimilars in the U.S. Business Wire

Fresenius Receives FDA Approval for their Denosumab Biosimilars and Secures Global Settlement Agreement Business Wire

Fresenius Kabi to announce the commercial launch of Otulfi™*, an approved Ustekinumab Biosimilar in Canada Yahoo Finance

CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code for Otulfi® (ustekinumab-aauz) Business Wire

Fresenius Kabi Introduces Calcitonin Salmon Injection, USP Synthetic Business Wire

Fresenius Kabi Receives FDA 510(k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora Xi Plasmapheresis System Yahoo Finance

Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio Business Wire

Fresenius Kabi Issues Ivenix Infusion Pump Software Update Letter: FDA AboutLawsuits.com

Fresenius Continues Growth of Biosimilars Portfolio with the U.S. Availability of Otulfi® (ustekinumab-aauz) Business Wire

Fresenius Kabi Submits 510(k) Notification for the Aurora Xi Plasmapheresis System Software Version 2.0 with New Nomogram Yahoo Finance

Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies GlobeNewswire

Generic Contrast Agents – Now You Have a Choice Radiology Business

Infusion Pump Software Correction: Fresenius Kabi Corrects Ivenix LVP fda.gov

Fresenius Kabi Goes Above and Beyond DSCSA Requirements with RFID Healthcare Packaging

Fresenius Kabi Receives 2024 Trailblazer Award From Premier Inc. for Supply Chain Innovation Business Wire

Fresenius Kabi and Mayo Clinic Enter into Multiyear Supply and Service Agreement for the Ivenix® Infusion System Business Wire

Fresenius Kabi Broadens Radiology Portfolio with its First-to-Market Authorized Generic, Sincalide for Injection Imaging Technology News

Fresenius Kabi Expands RFID Compatibility to Improve Hospital Inventory Management Business Wire

Fresenius Kabi Inducts 12 into National Blood Donation Hall of Fame Business Wire

Romidepsin for Injection Available from Fresenius Kabi Business Wire

Fresenius Kabi and Formycon Receive U.S. FDA Approval for Biosimilar Otulfi™* (ustekinumab-aauz) Business Wire

Fresenius Kabi Signs Exclusive U.S. Distribution Agreement with Corvida Medical for the HALO Business Wire

Fresenius Kabi Introduces Pralatrexate Injection for the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma Business Wire

Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections Business Wire

Fresenius Kabi and Health Care Logistics, Inc. Collaborate on RFID Compatibility Business Wire

Fresenius Kabi's Tocilizumab Biosimilar, Tyenne, Launches in US Market Center for Biosimilars

Fresenius Kabi Introduces New Generic for the Treatment of Multiple Myeloma Business Wire

Fresenius Kabi Expands Ready-to-Administer Portfolio with Glycopyrrolate Injection, USP Simplist® Prefilled Syringe Business Wire

Fresenius Kabi Launches Vasopressin Injection, USP Expanding U.S. Critical Care Portfolio Business Wire

Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection, USP Business Wire

Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent Business Wire

Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer Business Wire

Expanding Access to Women’s Health Fresenius Kabi Launches Generic Fertility Treatment Business Wire

Fresenius Kabi Introduces Smart Labels for Diprivan® with Embedded Fully Interoperable +RFID Technology Business Wire

Sedative that Received FDA Emergency Use Authorization Now Available from Fresenius Kabi for use in Mechanically Ventilated COVID-19 patients Business Wire

Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser Testing Yahoo Finance

Fresenius Kabi Announces Availability of Acetaminophen Injection for Intravenous use in Ready-to-Use freeflex® Bags Business Wire

Fresenius Kabi Introduces New Presentation for Fentanyl Citrate Injection, USP in Simplist Business Wire

CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code and Pass-Through Payment Status for Tyenne Business Wire

Temsirolimus Injection Now Available from Fresenius Kabi Business Wire

Fresenius Kabi Adds Micafungin for Injection to Expanding Anti-Infective Portfolio Business Wire

VFMCRP and Fresenius Kabi expand collaboration in nephrology in China with Veltassa® agreement Business Wire

Fresenius Kabi Expands Contrast Agent Portfolio with Launch of Gadoterate Meglumine Injection, USP Business Wire

Supporting Patient Safety: Fresenius Kabi Expands Ready-to-Administer Portfolio with Diazepam Injection, USP in Simplist® Prefilled Syringe Business Wire

Fresenius Kabi Introduces First-Ever Generic for Foscavir® (Foscarnet Sodium) Injection Business Wire

Fresenius Kabi Targets Treatment of Certain Seizures with Launch of Generic Lacosamide Injection, USP Business Wire

Fresenius Kabi Receives U.S. FDA Approval for Biosimilar Stimufend® (pegfilgrastim - fpgk) Business Wire

Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent Imaging Technology News

Fentanyl Citrate Injection, USP 50 mcg per 1 mL in Ready-to-Administer Prefilled Syringe Business Wire

Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa Business Wire

Fresenius Kabi Launches Icatibant Injection to Treat Acute Attacks of Hereditary Angioedema in Adults Business Wire

Fresenius Kabi Introduces Calcium Gluconate in Sodium Chloride Injection in Ready-to-Administer freeflex® Bags Business Wire

Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection, its First Product Compatible with Bluesight's KitCheck System Business Wire

Fresenius Kabi Receives FDA 510(k) Clearance for Wireless Agilia Connect Infusion System with Vigilant Software Suite-Vigilant Master Med Technology Diagnostic and Interventional Cardiology

Fresenius Kabi Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter Business Wire

Fresenius Kabi, a Leader in Injectable Medicines, Introduces Data Matrix Barcodes on all Drugs as part of Companywide Commitment to Medication Safety Business Wire

Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne Business Wire

Fresenius Kabi Introduces Low Concentration Heparin Sodium in Sodium Chloride Injection in Ready-to-Use Freeflex Business Wire

Fresenius Kabi Introduces Glucagon Emergency Medicine Kit to Treat Life-Threatening Episodes of Low Blood Sugar Business Wire

New Dosage Options of Potassium Phosphates Injection Available From Fresenius Kabi Medical Professionals Reference

Fresenius Kabi Further Expands Radiology Portfolio with Launch of Gadobutrol Injection Imaging Technology News

Stimufend® (pegfilgrastim-fpgk) Now Available in the United States Business Wire

IDACIO® (adalimumab-aacf) Now Available in the United States Business Wire

Fresenius Kabi’s Ivenix Infusion System Goes Live at San Luis Valley Health Business Wire

Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi PR Newswire Canada

FDA Approves Fresenius Kabi’s Tyenne, a Biosimilar of Actemra for the Treatment of Autoimmune Diseases Pharmaceutical Executive

Fresenius Kabi Recalls Dexmedetomidine Over Possible Lidocaine Cross-Contamination Medical Professionals Reference

Morphine Sulfate Injection, USP Ready-to-Administer Prefilled Syringes Business Wire

Fresenius Kabi Announces Availability of Potassium Phosphates Injection, USP in Three Presentations Business Wire

Small-Volume Presentation of Heparin Sodium Now Available in Simplist Prefilled Syringes Medical Professionals Reference

Recall: Lidocaine Identified in Dexmedetomidine Vials Medical Professionals Reference

Fresenius Kabi Introduces New Simplist(R) Fentanyl Citrate Injection, USP 50 mcg per 1 mL in Ready-to-Administer Prefilled Syringe Daily Freeman

Fresenius Kabi Receives 510(k) Clearance For The Fenwal Amicus Red Blood Cell Exchange Protocol Med Device Online

Fresenius Continues its Biopharma Momentum with Launch of Subcutaneous Formulation of Tyenne Business Wire

Fresenius Kabi Introduces Adenosine Injection, USP Simplist® Prefilled Syringes in 6 mg per 2 mL and 12 mg per 4 mL Presentations BioSpace

Diprivan® (Propofol) Injectable Emulsion, USP is First Product Available in Fresenius Kabi +RFID™ Portfolio of Smart-Labeled Medications Business Wire

Fresenius Kabi at ESPEN Virtual Congress 2021: EuroPN Study will provide new clinical data on critical care nutrition PR Newswire UK

Generic Version of Antifungal Drug Mycamine Now Available Medical Professionals Reference

Injectable NSAID Recalled Due to Particulate Matter Found in Vials Medical Professionals Reference

Fresenius Kabi Launches Acetylcysteine Solution Medical Professionals Reference

Fresenius Kabi Canada's ELONOX® & ELONOX® HP (enoxaparin sodium) - Biosimilars to Lovenox® are Now Available on every Provincial Formulary across Canada. PR Newswire Canada

Fresenius Kabi Canada Launches IDACIO® (adalimumab injection) a Biosimilar to HUMIRA® (adalimumab) for the Treatment of Multiple Chronic Inflammatory Conditions PR Newswire Canada

Liquid Presentation of Leucovorin Calcium Now Available Medical Professionals Reference

Supply problems with total parenteral nutrition (TPN) bags – Calea UK site in Runcorn, Cheshire GOV.UK

Fresenius Kabi issues voluntary recall of sodium acetate injection Medical Buyer

Fresenius Kabi COM.TEC initiates platelet aphaeresis at Army Hospital Daily Mirror - Sri Lanka